Optimal frontline therapy of chronic myeloid leukemia today, and related musings.

Autor: Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Begna K; Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Paul S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Welch MA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Jazyk: angličtina
Zdroj: American journal of hematology [Am J Hematol] 2024 Oct; Vol. 99 (10), pp. 1855-1861. Date of Electronic Publication: 2024 Aug 02.
DOI: 10.1002/ajh.27445
Databáze: MEDLINE